Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.1.1 Generators/Electrosurgical Unit 11
1.1.2 Ablation Catheters 11
1.1.3 Consumables 11
1.2 Microwave ablation (MWA) 13
1.3 Major Diseases Covered 13
1.3.1 Cancer 13
1.3.2 Cardiac Arrhythmias 14
1.4 Industry Trends 14
1.5 PEST Analysis 15
2 Report Outline 15
2.1 Report Scope 15
2.2 Report Summary 16
2.3 Research Methodology 17
2.4 Report Assumptions 17
3 Market Snapshot 18
3.1 Total Addressable Market (TAM) 18
3.2 Segmented Addressable Market (SAM) 19
3.3 Related Markets 23
3.3.1 Surgical Devices Market 23
3.3.2 Radiofrequency Ablation Devices Market 23
3.3.3 Ablation Catheters Market 23
3.3.4 Cardiac Ablation Market 24
4 Market Outlook 24
4.1 Overview 24
4.2 Importance of Microwave Ablation Devices 26
4.3 Porter 5(Five) Forces 26
4.4 Market Dynamics 27
4.4.1 Drivers 28
4.4.1.1 Rise in incidence of chronic disorders 28
4.4.1.2 Increasing popularity of MI surgeries 28
4.4.1.3 Increase in the number of outpatient procedures 29
4.4.1.4 Increasing market awareness and campaigns 29
4.4.1.5 Rise in elderly population 30
4.4.2 Opportunities 30
4.4.2.1 Technological advancements 30
4.4.2.1 High adoption of microwave for better support and improve patient outcome 31
4.4.2.2 Increasing healthcare spending 31
4.4.2.3 Shift towards minimal and non-invasive procedures 32
4.4.3 Restraints 32
4.4.3.1 Complications and risk associated with microwave ablation procedures 32
4.4.3.2 Presence of substitutes 33
4.4.3.3 High cost of microwave ablation procedures 33
4.4.3.4 Stringent regulatory approval process 34
4.4.3.5 Lack of skilled electrophysiologists 34
4.5 DRO - Impact Analysis 34
4.6 Key Stakeholders 35
5 Product Type: Market Size and Analysis 36
5.1 Overview 36
5.2 Generators/Electrosurgical Units 38
5.2.1 Overview 38
5.2.2 Featured Products: Generators/Electrosurgical Units 40
5.3 Consumables 40
5.3.1 Overview 40
5.3.2 Featured Products: Consumables 41
5.4 Microwave Ablation 42
6 Application 43
6.1 Oncology 43
6.2 Cardiovascular 43
6.3 Orthopedic 44
6.4 Urology 44
6.5 Gynecology 44
6.6 Others 45
7 End-Users 45
7.1 Overview 45
7.2 Hospitals 46
7.3 Ambulatory Care 47
7.3.1 ASCs in the Americas 47
7.3.1.1 US 47
7.3.1.2 Canada 48
7.3.1.3 Mexico 48
7.3.1.4 Cuba 48
7.3.2 ASCs in the EMEA Region 48
7.3.2.1 UK 48
7.3.2.2 Germany 48
7.3.2.1 France 48
7.3.2.2 Israel 48
7.3.2.3 Africa 48
7.3.3 ASCs in the APAC Region 49
7.3.3.1 Australia 49
7.3.3.2 Japan 49
7.3.3.3 India 49
7.3.3.4 China 49
7.4 Physician's Office 49
8 Regions: Market Size and Analysis 50
8.1 Overview 50
8.2 North America 53
8.2.1 Market Overview 53
8.3 Europe 55
8.3.1 Market Overview 55
8.4 APAC 56
8.4.1 Market Overview 57
8.5 Rest of the World 59
8.5.1 Market Overview 59
9 Competitive Landscape 61
9.1 Overview 62
10 Vendor Profiles 63
10.1 AngioDynamics' Inc. 64
10.1.1 Overview 64
10.1.2 Business Units 65
10.1.3 Geographic Presence 66
10.1.4 Business Focus 67
10.1.5 SWOT Analysis 67
10.1.6 Business Strategy 68
10.2 Johnson & Johnson (NeuWave Medical) 68
10.2.1 Overview 68
10.2.2 Business Units 72
10.2.3 Geographic Presence 73
10.2.4 Business Focus 74
10.2.5 SWOT Analysis 75
10.2.6 Business Strategy 75
10.3 Medtronic PLC 76
10.3.1 Overview 76
10.3.2 Business Units 78
10.3.3 Geographic Presence 79
10.3.4 Business Focus 80
10.3.5 SWOT Analysis 80
10.3.6 Business Strategy 81
10.4 MedWaves' Inc 82
10.4.1 Overview 82
10.4.2 Business Focus 82
10.4.3 SWOT Analysis 82
10.4.4 Business Strategy 83
10.5 Perseon 83
10.5.1 Overview 83
10.5.2 Business Focus 84
10.5.3 SWOT Analysis 84
10.5.4 Business Strategy 85
11 Companies to Watch For 85
11.1 Emblation Microwave. 85
11.1.1 Overview 85
11.1.2 Key Highlights 86
11.2 Miramar Labs. 86
11.2.1 Overview 86
11.2.2 Key Highlights 86
11.3 Urologix' LLC 87
11.3.1 Overview 87
11.4 Symple Surgical 87
Annexure 88
Abbreviations 88